AI-powered drug company spun out of Google’s DeepMind says human trials are ‘very close’ After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials.

Google DeepMind’s spin-off Isomorphic Labs says it’s almost ready to begin human testing for AI-designed drugs. Built on the success of AlphaFold, the company aims to speed up drug development in ...

A team from Google DeepMind and several universities introduces Aeneas, a generative (and free) AI model designed to help ...

Google DeepMind is getting ready to begin human testing of drugs developed using artificial intelligence. All you need to know ...

A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But can we trust drugs designed by a mind that isn't human?

Demis Hassabis, chief of Google DeepMind, believes there's a 50% chance of achieving AGI within 5 years. AGI means ...

Isomorphic Labs, a subsidiary of Alphabet Inc., is close to human trials for its AI-designed medicines. Other companies are also racing to use AI in drug discovery.

Co-founded by Elon Musk in 2016, Neuralink’s ‘patient one,’ Noland Arbaugh, received the first Brain Chip Implant (BCI) in ...

The "acqui-hire" strategy is on fire in this battle among tech titans seeking AI dominance and a Goliath just beat David ...

An artificial intelligence system built by Google DeepMind, the tech giant’s primary artificial intelligence lab, has ...